.Simply five months after securing a $one hundred million IPO, Boundless Bio is actually giving up s...
.The preliminary phases of oncology R&D aren't except interesting brand new techniques, and Halda...
.Psychopharmacology has actually taken 3 short articles about midstage medical trial information ass...
.Avidity Biosciences pleased entrepreneurs along with stage 1/2 records in Duchenne muscle dystrophy...
.Actinogen Medical's cortisol blocker has skipped the major endpoint of a phase 2 study in clinical ...
.Antibody-drug conjugates (ADCs) have been at the center of several a billion-dollar biobuck licensi...
.Property manager TPG, which has supported biotechs such as Sionna Therapies as well as Santa Clam A...
.Merck & Co.'s TIGIT system has suffered yet another trouble. Months after shuttering a stage 3 m...
.After a year defined by pipeline cuts, the variation of its own chief executive officer and also di...
.Cullinan Therapeutics was actually excited enough along with Harbour BioMed's bispecific immune sys...